Drawing for POPLAR THERAPEUTICS

USPTO serial 99571237

POPLAR THERAPEUTICS

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, THEODORE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POPLAR THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein Goodwin Procter LLP620 Eighth AvenueNew York, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of immunologic diseases and disordersACTIVE—
042Pharmaceutical research and development services in the field of immunologic diseases and disorders; providing information via a website in the field of research and development of pharmaceuticals in the field of immunologic diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 13, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 17, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 29, 2026DOCKASSIGNED TO EXAMINER—
Apr 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 30, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance